Fundz

Perceive Biotherapeutics reported raising $40 Million in an initial SEC Form D filing, from an offering of $78 Million

PRIVATEJan 13, 2023$40M of $78M raised

Amount Raised

$40 Million

$40 Million sold, per SEC Form D (first sale Dec 29, 2022)

Round Type

Venture

South San FranciscoBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Perceive Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Phylos raised $250K on February 10, 2023.
  • Codagenix raised $25M on February 10, 2023.
  • Interon Laboratories raised an undisclosed amount (Funding Round) on February 10, 2023.
  • Predicta Med raised an undisclosed amount (Funding Round) on February 10, 2023.
  • Evotec raised $161M (Debt Financing) on February 10, 2023.
  • MOLECULAR WORLD HEALTH raised $5K (Pre-Seed) on February 9, 2023.

Who to call at Perceive Biotherapeutics, and when

A new round usually means Perceive Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Perceive Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Perceive Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Perceive Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Perceive Biotherapeutics

Location

6000 SHORELINE DRIVE, SUITE 206

South San Francisco, California, United States

About

Perceive Biotherapeutics is advancing a deep and diversified pipeline of targets and treatment modalities in multiple therapeutic verticals, with lead pipeline programs in ophthalmology. Perceive was founded on compelling research elucidating two novel protective biologies for treating retinal blindness, developed from foundational collaborations in genetic science and target validation. The Company is backed by Deerfield Management, Braidwell LP, Retinal Degeneration Fund, the venture arm of the Foundation Fighting Blindness, Catalio Capital Management, LP and others. For more information, please visit www.perceivebio.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Perceive Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Perceive Biotherapeutics's next move

See what Strategic adds

Perceive Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.